Evidence map›Paper›PMID 31272399›Full record

ArticleBMC cancer2019

A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol.

A Singleton, S R Partridge, R Raeside, M Regimbal, K K Hyun, C K Chow, K Sherman, E Elder, J Redfern

Open access · goldAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

A SingletonFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia. anna.singleton@sydney.edu.au.ORCID http://orcid.org/0000-0002-7071-0118
S R PartridgeFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia.
R RaesideFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia.
M RegimbalFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia.
K K HyunFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia.
C K ChowFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia.
K ShermanCentre for Emotional Health, Department of Psychology, Macquarie University, Sydney, NSW, Australia.
E ElderWestmead Breast Cancer Institute, Westmead Hospital, Sydney, NSW, Australia.
J RedfernFaculty of Medicine and Health, Westmead Applied Research Centre (WARC), The University of Sydney, Westmead, NSW, Australia.
The University of Sydney · AUMacquarie University · AUWestmead Hospital · AU

Funding

National Health and Medical Research Council APP1105447National Health and Medical Research Council APP1143538National Health and Medical Research Council APP1157438National Heart Foundation of Australia HF102138National Heart Foundation of Australia HF102164Sydney Medical School N/A
6 · The paper itself

Abstract

backgroundBreast cancer is the most common cancer diagnosed in women worldwide. In developed countries, 80-90% of women will survive five years after diagnosis but the transition from hospital-based care to health self-management and self-efficacy can be difficult. Text messaging programs offer a simple and proven way to provide support to people with chronic diseases. This study aims to test the effectiveness of a text message support program at improving women's health self-efficacy, and physical and mental health outcomes after breast cancer treatments compared to usual care at 6-months and to understand the barriers and enablers to widespread implementation.

methodsSingle-blind randomised control trial (RCT; N = 160) comparing a text message support intervention to usual care in women with breast cancer (recruited from a large tertiary referral hospital in Sydney, Australia). The intervention group will receive a six-month text message support program, which consists of semi-personalised, supportive, lifestyle-focused text messages (4 messages/week) in addition to usual care. The control group will receive usual care without the text message program. Outcomes will be assessed at 6-months. The primary outcome is change in self-efficacy for managing chronic disease. Secondary outcomes include change in clinical outcomes (body mass index), lifestyle outcomes (physical activity levels, dietary behaviours), mood (depression and anxiety scales), quality of life, satisfaction with, and usefulness of the intervention. Analyses will be performed on the principle of intention-to-treat to examine differences between intervention and control groups. DISCUSSION: This study will test if a scalable and cost-effective text-messaging intervention is effective at improving women's health self-efficacy, as well as physical and mental health outcomes. Moreover, this study will provide essential preliminary data to bolster a large multicentre RCT to helpsupport breast cancer survivors throughout recovery and beyond.

trial registrationAustralia New Zealand Clinical Trials Registry (ANZCTR) number ACTRN12618002020268 , 17 December 2018.

Indexed as

Mental HealthPsychosocial Support SystemsText MessagingAffectAftercareAustraliaBody Mass IndexBreast NeoplasmsCancer SurvivorsChronic DiseaseFemaleFollow-Up StudiesHumansLife StyleQuality of LifeRandomized Controlled Trials as TopicBreast cancermHealthRandomised controlled trialSelf-efficacySupportSurvivorshipText messageTranslational research

Identifiers

PMID31272399
PMCPMC6610900
OpenAlexW2953902701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.